RABENLIV
Live / Registered — Registered (as of 31 Oct 2023)
What this means for you
Registered since 31 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97042250
- Registration number
- 7204455
- Mark type
- Design + words
- Filed
- 23 Sept 2021
- Published for opposition
- 15 Aug 2023
- Registered
- 31 Oct 2023
- Attorney of record
- John R. Guice, Jr.
Goods and services
- Class 001 — Chemicals: Vitamins for use in the manufacture of food supplements; antioxidants for use in the manufacture of food supplements; proteins for use in the manufacture of food supplements; tea extracts for the food industry; enzyme preparations for the food industry; casein for the food industry; pectin for the food industry; chemical substances for preserving foodstuffs; proteins for the food industry; tea extracts for use in the manufacture of pharmaceuticals; tea extracts for use in the manufacture of cosmetics; animal and vegetable albumin for use as a raw material in the manufacture of nutritional supplements; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; biological tissue cultures, other than for medical or veterinary purposes; chemical preservatives for the food industry, namely, for use in preserving foodstuffs; fruit preserving chemicals, namely, carboxymethyl cellulose; chemical preparations for use in manufacturing artificial sweeteners; lactose for the food industry; vitamins for the food industry; lecithin for the food industry
- Class 005 — Pharmaceuticals: Plant extracts for pharmaceutical purposes; powdered plant-based protein dietary supplements; dietetic preparations based on plant extracts for medical purposes; phytotherapy preparations for medical purposes; pharmaceutical drugs for treatment of liver diseases; anti-inflammatory preparations; anti-inflammatory gels; anti-inflammatory sprays; pharmaceutical preparations and substances with anti-inflammatory properties; galactolipid esters for pharmaceutical purposes; Chinese herbal extracts for medical purposes; Chinese medicines made of Chinese traditional medicinal herbs for human purposes; Chinese traditional medicinal herbs being medicine; traditional Chinese medicine made of Chinese traditional medicinal herbs; biocides; medicinal tea; milk sugar for pharmaceutical purposes; lactose for pharmaceutical purposes; nutritional supplements; antioxidants being dietary supplements; adhesive bandages; medicines for veterinary purposes for treatment of liver diseases; animal feed supplements for veterinary purposes; dietary supplements for veterinary purposes; food supplements for veterinary purposes; dietetic food and nutritive substances adapted for medical or veterinary use; food for babies; dietetic beverages for babies adapted for medical purposes; adhesive patches being bandages impregnated with pharmaceutical preparations; transdermal patches for medical treatment featuring galactolipid for an anti-inflammatory; medicated shampoos; medicated mouthwashes; medicated mouth rinses
Owner
- Greenyn Biotechnology Co., Ltd, Taichung City, TW
- Greenyn Biotechnology Co., Ltd, Taichung City, TW
- Greenyn Biotechnology Co., Ltd, Taichung City, TW
Prosecution history
- 31 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Aug 2023 — PUBLISHED FOR OPPOSITION
- 26 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jul 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 07 Jul 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 05 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jul 2023 — EXAMINER'S AMENDMENT ENTERED
- 05 Jul 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Jul 2023 — EXAMINERS AMENDMENT E-MAILED
- 05 Jul 2023 — EXAMINERS AMENDMENT -WRITTEN
- 18 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED